Burundi vs Cambodia: HIV-positive TB patients on ART (antiretroviral therapy)
Burundi
96.0%
in 2024
Cambodia
96.0%
in 2024
Burundi rank
74th
Cambodia rank
74th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Burundi
- Cambodia
How they compare
Burundi currently reports 96.0% against 96.0% in Cambodia, a difference of 0.0%.
The two have swapped places 8 times across 17 shared years of data; in 2008 it was Cambodia ahead.
Burundi ranks 74th and Cambodia ranks 74th of 144 countries.
Across the 3 decades both report, Burundi averaged higher in 2 and Cambodia in 1.
Head to head by decade
| Decade | Burundi | Cambodia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 23.0% | 18.5% | 4.5% | Burundi |
| 2010s | 75.5% | 88.0% | 12.5% | Cambodia |
| 2020s | 98.4% | 94.2% | 4.2% | Burundi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Burundi or Cambodia?
- Burundi, at 96.0% against 96.0% in Cambodia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Burundi and Cambodia?
- 0.0%, with Burundi ahead.
- How many years of comparable data are there for Burundi and Cambodia?
- 17 years are reported by both, from 2008 to 2024.
- How do Burundi and Cambodia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Burundi ranks 74th and Cambodia ranks 74th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.